Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study (Q33420695)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study |
scientific article |
Statements
1 reference
Randomized phase III trial of gemcitabine plus docetaxel plus bevacizumab or placebo as first-line treatment for metastatic uterine leiomyosarcoma: an NRG Oncology/Gynecologic Oncology Group study (English)
1 reference
Helen Michael
1 reference
Martee L Hensley
1 reference
Austin Miller
1 reference
David M O'Malley
1 reference
Robert S Mannel
1 reference
Kian Behbakht
1 reference
Jamie N Bakkum-Gamez
1 reference
23 February 2015
1 reference
1 reference
33
1 reference
10
1 reference
1180-1185
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference